Gevo, Inc.
GEVO issues statement regarding U.S. Patent and Trademark
Office (USPTO) announcement to grant the Butamax(TM) Advanced Biofuels,
LLC (Butamax) Request for Reexamination of Gevo's
(http://www.gevo.com/our-business/our-science-and-technology/) GIFT®
technology, U.S. Patent 8,101,808.
"Reexaminations are part of the normal course of a
(http://www.gevo.com/our-business/intellectual-property/) patent dispute,
especially when dealing with valuable technology. This reexamination
does not validate patent applications of Butamax or anyone else -- that
isn't what reexaminations do. The headline in the Butamax press release
is inflammatory and misleading.
Gevo's '808 Patent covers multiple production technologies for higher
alcohols in retrofitted ethanol plants. We believe that Butamax is
infringing at least one of those technologies. While our claims have
been set aside in this most recent USPTO action, Gevo's lawsuit against
Butamax for infringing this '808 Patent remains unaffected; the trial is
scheduled for July of 2014.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in